TP63 and head and neck squamous cell carcinoma: Taken together, our studies offer new mechanistic insights into the p63 regulatory network that is operational in HNSCC and identifies FST as a predictive biomarker and an attractive potential candidate for therapeutic targeting in HNSCC.